Sonavex Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
23
- Latest Deal Type
-
Series A2
- Latest Deal Amount
-
$15M
- Investors
-
38
Sonavex General Information
Description
Developer of a bioresorbable and echogenic equipment technology designed to mark at-risk blood vessels such that the site can be easily assessed for future complications. The company's technology collects arteriovenous fistula volumetric flow rate, diameter, and depth information at the dialysis clinic to support maturation assessment, enabling healthcare providers to assess blood flow and morphology of vessels and get actionable data to deliver patient care.
Contact Information
Website
www.sonavex.comCorporate Office
- 2835 O'Donnell Street
- Suite 200
- Baltimore, MD 21224
- United States
Corporate Office
- 2835 O'Donnell Street
- Suite 200
- Baltimore, MD 21224
- United States
Sonavex Timeline
Sonavex Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 17. Later Stage VC (Series A2) | 25-Oct-2024 | $15M | Completed | Clinical Trials - Phase 4 | ||
| 16. Secondary Transaction - Private | Completed | Clinical Trials - Phase 4 | ||||
| 15. Grant | 30-Jun-2022 | Completed | Clinical Trials - Phase 4 | |||
| 14. Grant | 25-May-2022 | Completed | Clinical Trials - Phase 4 | |||
| 13. Grant | 15-Sep-2021 | Completed | Clinical Trials - Phase 4 | |||
| 12. Accelerator/Incubator | 01-Jun-2020 | Completed | Clinical Trials - Phase 4 | |||
| 11. Debt - PPP | 15-Apr-2020 | Completed | Clinical Trials - Phase 4 | |||
| 10. Later Stage VC (Series A1) | 31-Jan-2020 | Completed | Clinical Trials - General | |||
| 9. Accelerator/Incubator | 01-Jan-2020 | $4.82M | Completed | Clinical Trials - Phase 1 | ||
| 8. Grant | 29-Aug-2019 | $3M | $4.82M | Completed | Clinical Trials - Phase 1 |
Sonavex Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Series A | 674,237 | $0.000100 | $7.04 | $7.04 | 1x | $7.04 | 20.09% | |
| Seed | 140,464 | $0.000100 | $2.37 | $2.37 | 1x | $2.37 | 4.19% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Sonavex Comparisons
Industry
Financing
Details
Sonavex Competitors (8)
One of Sonavex’s 8 competitors is Alio, a Venture Capital-Backed company based in Broomfield, CO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alio | Venture Capital-Backed | Broomfield, CO | ||||
| EchoNous | Private Equity-Backed | Redmond, WA | ||||
| Synaptive Medical | Venture Capital-Backed | Toronto, Canada | ||||
| Monteris Medical | Venture Capital-Backed | Minnetonka, MN | ||||
| Butterfly Network | Formerly VC-backed | Burlington, MA |
Sonavex Patents
Sonavex Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200139592-A1 | Microcavity-containing polymeric medical devices for enhanced ultrasonic echogenicity | Inactive | 16-Jul-2015 | ||
| EP-3322345-A1 | Microcavity-containing polymeric medical devices for enhanced ultrasonic echogenicity | Pending | 16-Jul-2015 | ||
| AU-2016293866-A1 | Microcavity-containing polymeric medical devices for enhanced ultrasonic echogenicity | Inactive | 16-Jul-2015 | ||
| US-20170014102-A1 | Microcavity-containing polymeric medical devices for enhanced ultrasonic echogenicity | Inactive | 16-Jul-2015 | ||
| JP-2018522698-A | Polymer medical devices containing microcavities for enhancing ultrasound echo brightness | Pending | 16-Jul-2015 | B29C44/02 |
Sonavex Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sonavex Investors (38)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Accelerator Venture Partners | Venture Capital | Minority | ||
| Biohealth Innovation | Corporation | Minority | ||
| GenHenn Capital | Family Office | Minority | ||
| JStar Capital | PE/Buyout | Minority | ||
| Keiretsu Forum | Venture Capital | Minority |
Sonavex FAQs
-
When was Sonavex founded?
Sonavex was founded in 2013.
-
Where is Sonavex headquartered?
Sonavex is headquartered in Baltimore, MD.
-
What is the size of Sonavex?
Sonavex has 23 total employees.
-
What industry is Sonavex in?
Sonavex’s primary industry is Monitoring Equipment.
-
Is Sonavex a private or public company?
Sonavex is a Private company.
-
What is the current valuation of Sonavex?
The current valuation of Sonavex is .
-
What is Sonavex’s current revenue?
The current revenue for Sonavex is .
-
How much funding has Sonavex raised over time?
Sonavex has raised $24.1M.
-
Who are Sonavex’s investors?
Accelerator Venture Partners, Biohealth Innovation, GenHenn Capital, JStar Capital, and Keiretsu Forum are 5 of 38 investors who have invested in Sonavex.
-
Who are Sonavex’s competitors?
Alio, EchoNous, Synaptive Medical, Monteris Medical, and Butterfly Network are some of the 8 competitors of Sonavex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
